These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 24635967

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors: is there a real link?
    Sarikaya M, Filik L, Ergul B, Doğan Z.
    Gastroenterol Nurs; 2013; 36(2):145-8. PubMed ID: 23549219
    [No Abstract] [Full Text] [Related]

  • 23. A diffuse desquamative rash in an elderly male.
    Roman J, Nguyen KD, Dominguez AR.
    Int J Dermatol; 2017 Aug; 56(8):e170-e172. PubMed ID: 28251610
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
    Dabholkar AH, Han C, Paris MM, Perez MC, Atkinson SN, Peura DA.
    Aliment Pharmacol Ther; 2011 Feb; 33(3):366-77. PubMed ID: 21118280
    [Abstract] [Full Text] [Related]

  • 26. Dexlansoprazole MR: a review.
    Hershcovici T, Jha LK, Fass R.
    Ann Med; 2011 Aug; 43(5):366-74. PubMed ID: 21366513
    [Abstract] [Full Text] [Related]

  • 27. Proton pump inhibitor-induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus.
    Hung R, Sangle SR, Benton E, D'Cruz DP, McGibbon D.
    Clin Exp Dermatol; 2015 Oct; 40(7):808-9. PubMed ID: 25809120
    [No Abstract] [Full Text] [Related]

  • 28. [Efficacy of pantoprazole in the therapy of esophageal reflux disease].
    Lazebnik LB, Vasil'ev IuV.
    Eksp Klin Gastroenterol; 2008 Oct; (2):102-4. PubMed ID: 19145874
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Lansoprazole-induced subacute cutaneous lupus erythematosus.
    Panting KJ, Pinto M, Ellison J.
    Clin Exp Dermatol; 2009 Aug; 34(6):733-4. PubMed ID: 19508577
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ziprasidone-induced sub acute cutaneous lupus erythematosus.
    M Quintana Codina, L Creus Vila, G Melé Ninot, M Salleras Redonnet.
    Lupus; 2017 Jun; 26(7):785-786. PubMed ID: 27838681
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hypomagnesemia associated with a proton pump inhibitor.
    Matsuyama J, Tsuji K, Doyama H, Kim F, Takeda Y, Kito Y, Ito R, Nakanishi H, Hayashi T, Waseda Y, Tsuji S, Takemura K, Yamada S, Okada T, Kanaya H.
    Intern Med; 2012 Jun; 51(16):2231-4. PubMed ID: 22892510
    [Abstract] [Full Text] [Related]

  • 38. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
    Kunsch S, Neesse A, Linhart T, Steinkamp M, Fensterer H, Adler G, Gress TM, Ellenrieder V.
    Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.